Using heart pump support for complex high-risk procedures
Part of Heart & circulation clinical trials.
This trial is testing whether using a special heart pump (PulseCath iVAC2L) during complex, high-risk angioplasty can help people with very weak hearts. It's for people who need a procedure for complicated coronary artery blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your heart team has agreed that you need a high-risk angioplasty (with or without heart pump support).
- You are stable enough for the procedure (not in cardiogenic shock).
- Your heart's pumping strength is very low (less than 30%, or less than 35% with moderate valve leakage, or less than 40% with severe valve leakage).
- You have a complex blockage in the left main coronary artery or an equivalent serious blockage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This study tracks patients with weakened heart function who undergo complex stent procedures (PCI) instead of open-heart surgery. Researchers will follow your progress to understand how well these procedures work in patients who are too sick for traditional bypass surgery.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This trial tests a tiny heart pump to support blood flow during a procedure to open blocked arteries in people with very weak hearts (less than 35% pumping strength). It aims to see if this pump makes the procedure safer and more effective.
Hear when a new High-risk PCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.